The synthesis and characterization of new triphenylethylene platinum(II) complexes

被引:12
作者
Berube, G
He, YH
Groleau, S
Sene, A
Therien, HM
Caron, M
机构
[1] Dept. de Chimie-biologie, Univ. Quebec Trois-Rivieres, C.P., Trois-Rivières
基金
英国医学研究理事会;
关键词
platinum complexes; triphenylethylene complexes; cytotoxic complexes;
D O I
10.1016/S0020-1693(97)05514-X
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
In our search for a chemotherapeutic agent with a better therapeutic index and selectivity for the treatment of breast cancer, we have synthesized a series of cytotoxic analogs of tamoxifen. The new triphenylethylene platinum(II) derivatives were designed to possess binding affinity for the estrogen receptor. The synthesis of this type of compound is straightforward and efficient. The new complexes were fully characterized by their IR, H-1 NMR and C-13 NMR spectra as well as their elemental analysis. The estrogen receptor binding affinity (RBA) of some of these triphenylethylenes was also evaluated and was found to be comparable to the affinity of the reference drug, i.e, tamoxifen, RBA=1.3%.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 39 条
[1]  
ALAOUIJAMALI M, 1994, CANCER CHEMOTH PHARM, V34, P153
[2]   ENHANCED REPAIR OF A CISPLATIN-DAMAGED REPORTER CHLORAMPHENICOL-O-ACETYLTRANSFERASE GENE AND ALTERED ACTIVITIES OF DNA-POLYMERASES ALPHA AND BETA, AND DNA-LIGASE IN CELLS OF A HUMAN-MALIGNANT GLIOMA FOLLOWING IN-VIVO CISPLATIN THERAPY [J].
ALIOSMAN, F ;
BERGER, MS ;
RAIRKAR, A ;
STEIN, DE .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, 54 (01) :11-19
[3]  
[Anonymous], ORG SYNTHESIS COLLEC
[4]   HYDROXYLATED 2,3-DIARYLINDENES - SYNTHESIS, ESTROGEN-RECEPTOR BINDING-AFFINITY, AND BINDING ORIENTATION CONSIDERATIONS [J].
ANSTEAD, GM ;
PETERSON, CS ;
KATZENELLENBOGEN, JA .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 33 (05) :877-887
[5]  
ARTEAGA CL, 1987, CANCER RES, V47, P6248
[6]   SYNTHESIS AND PRELIMINARY IN-VITRO BIOLOGICAL-ACTIVITY OF NONSTEROIDAL CYTOTOXIC ESTROGENS DESIGNED FOR THE TREATMENT OF BREAST-CANCER [J].
BERUBE, G ;
WHEELER, P ;
FORD, CHJ ;
GALLANT, M ;
TSALTAS, Z .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1993, 71 (09) :1327-1333
[7]  
BOWLER J, 1989, Steroids, V54, P71, DOI 10.1016/0039-128X(89)90076-7
[8]  
CHERIAN MG, 1994, TOXICOL APPL PHARM, V126, P1, DOI 10.1006/taap.1994.1083
[9]   RESISTANCE TO CISPLATIN AND ANALOGS - MECHANISMS AND POTENTIAL CLINICAL IMPLICATIONS [J].
DEGRAEFF, A ;
SLEBOS, RJC ;
RODENHUIS, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) :325-332
[10]  
FORD JM, 1990, PHARMACOL REV, V42, P155